O Shaughnessy Asset Management LLC Trims Stock Position in Humana Inc. (NYSE:HUM)

O Shaughnessy Asset Management LLC lessened its holdings in Humana Inc. (NYSE:HUM) by 56.1% during the 1st quarter, Holdings Channel reports. The firm owned 8,204 shares of the insurance provider’s stock after selling 10,485 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Humana were worth $2,845,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Rakuten Securities Inc. purchased a new stake in shares of Humana in the fourth quarter valued at about $25,000. Gradient Investments LLC lifted its stake in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the period. Cetera Trust Company N.A purchased a new position in shares of Humana during the fourth quarter valued at approximately $28,000. Private Wealth Management Group LLC purchased a new position in shares of Humana during the fourth quarter valued at approximately $32,000. Finally, Carolinas Wealth Consulting LLC lifted its stake in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after buying an additional 74 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Up 0.1 %

NYSE HUM traded up $0.43 during trading hours on Wednesday, reaching $386.30. 860,030 shares of the company traded hands, compared to its average volume of 1,746,547. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $46.55 billion, a PE ratio of 24.13, a PEG ratio of 2.23 and a beta of 0.51. The company has a 50 day moving average of $363.52 and a two-hundred day moving average of $347.00.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the prior year, the firm posted $9.38 EPS. The firm’s revenue was up 10.7% compared to the same quarter last year. As a group, equities analysts expect that Humana Inc. will post 16.27 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on HUM shares. Truist Financial upped their price objective on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. Wells Fargo & Company reduced their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Barclays reduced their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. UBS Group reduced their price objective on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research note on Thursday, April 25th. Finally, Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $402.60.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.